<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02551770</url>
  </required_header>
  <id_info>
    <org_study_id>CR 01/15</org_study_id>
    <nct_id>NCT02551770</nct_id>
  </id_info>
  <brief_title>Emdogain Minimally Invasive Surgical Technique</brief_title>
  <official_title>Straumann® Emdogain® Application In Conjunction With Minimally Invasive Surgical Technique For Periodontal Disease Treatment: A Split-Mouth Design Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Straumann AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut Straumann AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this controlled study is to assess the clinical outcomes and patient reported
      outcomes of using minimally invasive surgical procedure with Straumann Emdogain as an adjunct
      (test treatment) or without Straumann Emdogain (control treatment).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study will be achieved through the following primary and secondary objectives.
      The primary objective is to evaluate the regenerative potential of Straumann Emdogain by
      comparing the change in clinical attachment level from baseline to 12 months between the test
      and control arms. The regenerative potential of Straumann Emdogain will also be assessed by
      comparing the changes in gingival margins, changes in average probing pocket depth, changes
      in full mouth plaque score, changes in bleeding on probing, and changes in root dentin
      hypersensitivity from baseline to 12 months between the test and control arms.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2015</start_date>
  <completion_date type="Actual">August 30, 2019</completion_date>
  <primary_completion_date type="Actual">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Clinical Attachment Levels (CAL)</measure>
    <time_frame>Baseline and 12 Month Follow-Up Visit</time_frame>
    <description>CAL will be measured in millimeters on the study teeth at 6 locations. Outcome is mean change of CAL from baseline measurements at surgery to 12-months post-surgery, taken from the deepest pocket of a patient's test and control teeth measured at baseline. Analysis will compare the mean change of CAL for test and control treatment arms.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Gingival Margin (GM)</measure>
    <time_frame>Baseline and 12 Month Follow-Up Visit</time_frame>
    <description>GM will be measured in millimeters on the study teeth at 6 locations. Outcome is mean change of GM from baseline at surgery to 12-months-post surgery, taken from the deepest pocket of a patient's test and control teeth measured at baseline. Analysis will compare the mean change of GM for test and control treatment arms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Pocket Probing Depth (PPD)</measure>
    <time_frame>Baseline and 12 Month Follow-Up Visit</time_frame>
    <description>PPD will be measured in millimeters on the study teeth in 6 locations. Outcome is mean change of PPD from baseline at surgery to 12-months post-surgery, taken from the deepest pocket of a patient's test and control teeth at baseline. Analysis will compare the mean change of PPD for test and control treatment arms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Full Mouth Plaque Score (FMPS)</measure>
    <time_frame>Baseline and 12 Month Follow-Up Visit</time_frame>
    <description>FMPS will be calculated based on the number of tooth surfaces with plaque over the total number of tooth surfaces x 100. The value is presented as a percent. The difference in FMPS between 12 months and baseline will be determined.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Bleeding on Probing (BoP)</measure>
    <time_frame>Baseline and 12 Month Follow-Up Visit</time_frame>
    <description>For the categorical variable BoP, the frequency of bleeding (present or absent) will be counted (absolute and in percent) over all measured sites around the identified study teeth for each treatment group. The results will be compared between the 12-month follow-up and baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Root Dentin Hypersensitivity</measure>
    <time_frame>Baseline and 12 Month Follow-Up Visit</time_frame>
    <description>Presence of root dentin hypersensitivity will be recorded as &quot;none&quot; (no reaction from the subject), &quot;mild&quot; (sensible with no pain), &quot;moderate&quot; (sensible with slight pain), or &quot;severe&quot; (sensible with pain that persists for a while) after a conventional air blast is applied to the study tooth. Changes in the frequency of categories will be determined and compared between the two treatment arms. An improvement is defined as a decreased reaction (for example, severe to mild), a deterioration is defined as increased reaction (for example, none to moderate), and unchanged is no change to reaction (for example, mild to mild).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Post-surgical Pain</measure>
    <time_frame>1-2 days post surgery, 1 week post surgery, and 2 weeks post surgery</time_frame>
    <description>Post-surgical pain will be measured on a 100 millimeter visual analog scale. The range is 0 (no pain) to 99 (nearly maximum pain). The lower the value, the better the outcome. The subjects will be instructed to mark their level of pain on a line for both the test quadrant and the control quadrant. The average change in pain level will be determined and compared between the two arms.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Periodontitis</condition>
  <arm_group>
    <arm_group_label>Test (with Emdogain)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Scaling and root planing with Emdogain</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control (without Emdogain)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Scaling and root planing without Emdogain</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Scaling and root planing</intervention_name>
    <description>Using minimally invasive surgical procedure (scaling and root planing) with Emdogain application to treat one contra-lateral quadrant in subject's jaw.</description>
    <arm_group_label>Test (with Emdogain)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Scaling and root planing without Emdogain</intervention_name>
    <description>Using minimally invasive surgical procedure (scaling and root planing) without Emdogain application to treat one contra-lateral quadrant in subject's jaw.</description>
    <arm_group_label>Control (without Emdogain)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Emdogain application</intervention_name>
    <description>Using minimally invasive surgical procedure (scaling and root planing) with Emdogain application to treat one contra-lateral quadrant in subject's jaw</description>
    <arm_group_label>Test (with Emdogain)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects must have voluntarily signed the informed consent form before any study
             related procedures

          -  Subjects must be males or females who are 18-85 years of age

          -  Subjects must have moderate to severe chronic, generalized periodontitis with pockets
             of 5 mm - 8mm probing depth in at least 2 pockets per contralateral quadrants in one
             arch (study teeth)

          -  Subjects must be committed to the study and the required follow-up visits

          -  Subjects must be in good general health as assessed by the Investigator

        Exclusion Criteria:

          -  Subjects taking or intending to take any medications during the duration of the study
             that will potentially affect healing and inflammation

          -  Subjects who are currently heavy smokers (defined &gt;10 cigarettes per day or &gt;1 cigar
             per day) or who use chewing tobacco

          -  Subjects being treated with systemic antibiotics or subjects that were treated with
             systemic antibiotics within 3 months prior to treatment in this study

          -  Subjects with uncontrolled diabetes

          -  Subjects that are immunocompromised or immunosuppressed

          -  Subjects that cannot provide informed consent

          -  Subjects with drug or alcohol abuse

          -  Subjects that have undergone periodontal root planing or periodontal surgery in the
             last 6 months

          -  Subjects that are pregnant

          -  Subjects with necrotizing periodontitis or periodontitis related to systemic disease

          -  Teeth with pockets with probing depth ≥ 9 mm will not classify as study teeth

          -  Teeth with pockets or defects with furcation involvement will not classify as study
             teeth

          -  Teeth with mobility degree &gt; 1 without splint will not classify as study teeth

          -  Subjects with test and control sites in the two quadrants on adjacent teeth

          -  Patients with compromised health conditions such as diabetes, systemic diseases, high
             dose steroid therapy, bone metabolic diseases, radiation or immune-oppressive therapy,
             and infections or vascular impairment at the surgical site

          -  Subjects with conditions or circumstances, in the opinion of the Investigator , which
             would prevent completion of study participation or interfere with analysis of study
             results
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pamela K McClain, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Periodontics and Implant Dentistry</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Veronique Benhamou, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinique Paro Excellence</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jennifer H Doobrow, DMD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Periodontal &amp; Implant Associates</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Periodontal and Implant Associates, Inc.</name>
      <address>
        <city>Cullman</city>
        <state>Alabama</state>
        <zip>35055</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Periodontics and Implant Dentistry</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80012-3202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Paro Excellence</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3B 3A7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin der Johannes Gutenberg Universität Mainz</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Germany</country>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>September 14, 2015</study_first_submitted>
  <study_first_submitted_qc>September 14, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2015</study_first_posted>
  <results_first_submitted>August 30, 2019</results_first_submitted>
  <results_first_submitted_qc>October 16, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">October 17, 2019</results_first_posted>
  <disposition_first_submitted>April 9, 2019</disposition_first_submitted>
  <disposition_first_submitted_qc>April 9, 2019</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">April 17, 2019</disposition_first_posted>
  <last_update_submitted>October 16, 2019</last_update_submitted>
  <last_update_submitted_qc>October 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 9, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/70/NCT02551770/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Oversight. 1 extra patient was enrolled.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Test (With Emdogain)</title>
          <description>Scaling and root planing with Emdogain
Scaling and root planing: Using minimally invasive surgical procedure (scaling and root planing) with Emdogain application to treat one contra-lateral quadrant in subject's jaw.
Emdogain application: Using minimally invasive surgical procedure (scaling and root planing) with Emdogain application to treat one contra-lateral quadrant in subject's jaw</description>
        </group>
        <group group_id="P2">
          <title>Control (Without Emdogain)</title>
          <description>Scaling and root planing without Emdogain
Scaling and root planing without Emdogain: Using minimally invasive surgical procedure (scaling and root planing) without Emdogain application to treat one contra-lateral quadrant in subject's jaw.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="51"/>
                <participants group_id="P2" count="51"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="48"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>All Participants</title>
          <description>Participants assigned to receive both interventions (i.e., control and test) in different quadrants of the jaw.
- Test Treatment (Scaling and root planing with Emdogain): Scaling and root planing: Using minimally invasive surgical procedure (scaling and root planing) with Emdogain application to treat one contra-lateral quadrant in subject's jaw.
Emdogain application: Using minimally invasive surgical procedure (scaling and root planing) with Emdogain application to treat one contra-lateral quadrant in subject's jaw.
- Control Treatment (Scaling and root planing): Scaling and root planing: Using minimally invasive surgical procedure (scaling and root planing) to treat one contra-lateral quadrant in subject's jaw.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="51"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;18</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18-85</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;85</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Germany</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Clinical Attachment Levels (CAL)</title>
        <description>CAL will be measured in millimeters on the study teeth at 6 locations. Outcome is mean change of CAL from baseline measurements at surgery to 12-months post-surgery, taken from the deepest pocket of a patient's test and control teeth measured at baseline. Analysis will compare the mean change of CAL for test and control treatment arms.</description>
        <time_frame>Baseline and 12 Month Follow-Up Visit</time_frame>
        <population>The ITT data set with imputation of missing values (five CAL values were missing at 12 month follow-up and were replaced with values from 9 month follow-up).</population>
        <group_list>
          <group group_id="O1">
            <title>Test (With Emdogain)</title>
            <description>Scaling and root planing with Emdogain
Scaling and root planing: Using minimally invasive surgical procedure (scaling and root planing) with Emdogain application to treat one contra-lateral quadrant in subject's jaw.
Emdogain application: Using minimally invasive surgical procedure (scaling and root planing) with Emdogain application to treat one contra-lateral quadrant in subject's jaw</description>
          </group>
          <group group_id="O2">
            <title>Control (Without Emdogain)</title>
            <description>Scaling and root planing without Emdogain
Scaling and root planing without Emdogain: Using minimally invasive surgical procedure (scaling and root planing) without Emdogain application to treat one contra-lateral quadrant in subject's jaw.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Clinical Attachment Levels (CAL)</title>
          <description>CAL will be measured in millimeters on the study teeth at 6 locations. Outcome is mean change of CAL from baseline measurements at surgery to 12-months post-surgery, taken from the deepest pocket of a patient's test and control teeth measured at baseline. Analysis will compare the mean change of CAL for test and control treatment arms.</description>
          <population>The ITT data set with imputation of missing values (five CAL values were missing at 12 month follow-up and were replaced with values from 9 month follow-up).</population>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.2" spread="1.5"/>
                    <measurement group_id="O2" value="-2.1" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Gingival Margin (GM)</title>
        <description>GM will be measured in millimeters on the study teeth at 6 locations. Outcome is mean change of GM from baseline at surgery to 12-months-post surgery, taken from the deepest pocket of a patient's test and control teeth measured at baseline. Analysis will compare the mean change of GM for test and control treatment arms.</description>
        <time_frame>Baseline and 12 Month Follow-Up Visit</time_frame>
        <population>from the ITT dataset. Missing data was not entered.</population>
        <group_list>
          <group group_id="O1">
            <title>Test (With Emdogain)</title>
            <description>Scaling and root planing with Emdogain
Scaling and root planing: Using minimally invasive surgical procedure (scaling and root planing) with Emdogain application to treat one contra-lateral quadrant in subject's jaw.
Emdogain application: Using minimally invasive surgical procedure (scaling and root planing) with Emdogain application to treat one contra-lateral quadrant in subject's jaw</description>
          </group>
          <group group_id="O2">
            <title>Control (Without Emdogain)</title>
            <description>Scaling and root planing without Emdogain
Scaling and root planing without Emdogain: Using minimally invasive surgical procedure (scaling and root planing) without Emdogain application to treat one contra-lateral quadrant in subject's jaw.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Gingival Margin (GM)</title>
          <description>GM will be measured in millimeters on the study teeth at 6 locations. Outcome is mean change of GM from baseline at surgery to 12-months-post surgery, taken from the deepest pocket of a patient's test and control teeth measured at baseline. Analysis will compare the mean change of GM for test and control treatment arms.</description>
          <population>from the ITT dataset. Missing data was not entered.</population>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="47"/>
                <count group_id="O2" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-.3" spread=".9"/>
                    <measurement group_id="O2" value="-.2" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Pocket Probing Depth (PPD)</title>
        <description>PPD will be measured in millimeters on the study teeth in 6 locations. Outcome is mean change of PPD from baseline at surgery to 12-months post-surgery, taken from the deepest pocket of a patient's test and control teeth at baseline. Analysis will compare the mean change of PPD for test and control treatment arms.</description>
        <time_frame>Baseline and 12 Month Follow-Up Visit</time_frame>
        <population>ITT dataset.</population>
        <group_list>
          <group group_id="O1">
            <title>Test (With Emdogain)</title>
            <description>Scaling and root planing with Emdogain
Scaling and root planing: Using minimally invasive surgical procedure (scaling and root planing) with Emdogain application to treat one contra-lateral quadrant in subject's jaw.
Emdogain application: Using minimally invasive surgical procedure (scaling and root planing) with Emdogain application to treat one contra-lateral quadrant in subject's jaw</description>
          </group>
          <group group_id="O2">
            <title>Control (Without Emdogain)</title>
            <description>Scaling and root planing without Emdogain
Scaling and root planing without Emdogain: Using minimally invasive surgical procedure (scaling and root planing) without Emdogain application to treat one contra-lateral quadrant in subject's jaw.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Pocket Probing Depth (PPD)</title>
          <description>PPD will be measured in millimeters on the study teeth in 6 locations. Outcome is mean change of PPD from baseline at surgery to 12-months post-surgery, taken from the deepest pocket of a patient's test and control teeth at baseline. Analysis will compare the mean change of PPD for test and control treatment arms.</description>
          <population>ITT dataset.</population>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="47"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.4" spread="1.3"/>
                    <measurement group_id="O2" value="-2.3" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Full Mouth Plaque Score (FMPS)</title>
        <description>FMPS will be calculated based on the number of tooth surfaces with plaque over the total number of tooth surfaces x 100. The value is presented as a percent. The difference in FMPS between 12 months and baseline will be determined.</description>
        <time_frame>Baseline and 12 Month Follow-Up Visit</time_frame>
        <population>ITT data set.</population>
        <group_list>
          <group group_id="O1">
            <title>Test (With Emdogain)</title>
            <description>Scaling and root planing with Emdogain
Scaling and root planing: Using minimally invasive surgical procedure (scaling and root planing) with Emdogain application to treat one contra-lateral quadrant in subject's jaw.
Emdogain application: Using minimally invasive surgical procedure (scaling and root planing) with Emdogain application to treat one contra-lateral quadrant in subject's jaw</description>
          </group>
          <group group_id="O2">
            <title>Control (Without Emdogain)</title>
            <description>Scaling and root planing without Emdogain
Scaling and root planing without Emdogain: Using minimally invasive surgical procedure (scaling and root planing) without Emdogain application to treat one contra-lateral quadrant in subject's jaw.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Full Mouth Plaque Score (FMPS)</title>
          <description>FMPS will be calculated based on the number of tooth surfaces with plaque over the total number of tooth surfaces x 100. The value is presented as a percent. The difference in FMPS between 12 months and baseline will be determined.</description>
          <population>ITT data set.</population>
          <units>Full Mouth Plaque Score</units>
          <param>Number</param>
          <units_analyzed>Tooth surfaces</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="51"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Tooth surfaces</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="668"/>
                <count group_id="O2" value="684"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="51"/>
                    <count group_id="O2" value="51"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Tooth surfaces</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="668"/>
                    <count group_id="O2" value="684"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.34"/>
                    <measurement group_id="O2" value="55.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 Month Follow Up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="51"/>
                    <count group_id="O2" value="51"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Tooth surfaces</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="612"/>
                    <count group_id="O2" value="604"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.03"/>
                    <measurement group_id="O2" value="31.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Bleeding on Probing (BoP)</title>
        <description>For the categorical variable BoP, the frequency of bleeding (present or absent) will be counted (absolute and in percent) over all measured sites around the identified study teeth for each treatment group. The results will be compared between the 12-month follow-up and baseline.</description>
        <time_frame>Baseline and 12 Month Follow-Up Visit</time_frame>
        <population>ITT data set.</population>
        <group_list>
          <group group_id="O1">
            <title>Test (With Emdogain)</title>
            <description>Scaling and root planing with Emdogain
Scaling and root planing: Using minimally invasive surgical procedure (scaling and root planing) with Emdogain application to treat one contra-lateral quadrant in subject's jaw.
Emdogain application: Using minimally invasive surgical procedure (scaling and root planing) with Emdogain application to treat one contra-lateral quadrant in subject's jaw</description>
          </group>
          <group group_id="O2">
            <title>Control (Without Emdogain)</title>
            <description>Scaling and root planing without Emdogain
Scaling and root planing without Emdogain: Using minimally invasive surgical procedure (scaling and root planing) without Emdogain application to treat one contra-lateral quadrant in subject's jaw.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Bleeding on Probing (BoP)</title>
          <description>For the categorical variable BoP, the frequency of bleeding (present or absent) will be counted (absolute and in percent) over all measured sites around the identified study teeth for each treatment group. The results will be compared between the 12-month follow-up and baseline.</description>
          <population>ITT data set.</population>
          <units>Sites</units>
          <param>Count of Units</param>
          <units_analyzed>Sites</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="51"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Sites</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1002"/>
                <count group_id="O2" value="1026"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline sites with bleeding</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="51"/>
                    <count group_id="O2" value="51"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Sites</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1002"/>
                    <count group_id="O2" value="1026"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="547"/>
                    <measurement group_id="O2" value="576"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline sites without bleeding</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="51"/>
                    <count group_id="O2" value="51"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Sites</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1002"/>
                    <count group_id="O2" value="1026"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="455"/>
                    <measurement group_id="O2" value="450"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 month sites with bleeding</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="51"/>
                    <count group_id="O2" value="51"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Sites</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="969"/>
                    <count group_id="O2" value="966"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="172"/>
                    <measurement group_id="O2" value="223"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 month sites without bleeding</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="51"/>
                    <count group_id="O2" value="51"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Sites</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="969"/>
                    <count group_id="O2" value="966"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="797"/>
                    <measurement group_id="O2" value="743"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Root Dentin Hypersensitivity</title>
        <description>Presence of root dentin hypersensitivity will be recorded as &quot;none&quot; (no reaction from the subject), &quot;mild&quot; (sensible with no pain), &quot;moderate&quot; (sensible with slight pain), or &quot;severe&quot; (sensible with pain that persists for a while) after a conventional air blast is applied to the study tooth. Changes in the frequency of categories will be determined and compared between the two treatment arms. An improvement is defined as a decreased reaction (for example, severe to mild), a deterioration is defined as increased reaction (for example, none to moderate), and unchanged is no change to reaction (for example, mild to mild).</description>
        <time_frame>Baseline and 12 Month Follow-Up Visit</time_frame>
        <population>ITT data set study teeth. Baseline collected at either visit 1 or visit 2 based on different versions of CIP.</population>
        <group_list>
          <group group_id="O1">
            <title>Test (With Emdogain)</title>
            <description>Scaling and root planing with Emdogain
Scaling and root planing: Using minimally invasive surgical procedure (scaling and root planing) with Emdogain application to treat one contra-lateral quadrant in subject's jaw.
Emdogain application: Using minimally invasive surgical procedure (scaling and root planing) with Emdogain application to treat one contra-lateral quadrant in subject's jaw</description>
          </group>
          <group group_id="O2">
            <title>Control (Without Emdogain)</title>
            <description>Scaling and root planing without Emdogain
Scaling and root planing without Emdogain: Using minimally invasive surgical procedure (scaling and root planing) without Emdogain application to treat one contra-lateral quadrant in subject's jaw.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Root Dentin Hypersensitivity</title>
          <description>Presence of root dentin hypersensitivity will be recorded as &quot;none&quot; (no reaction from the subject), &quot;mild&quot; (sensible with no pain), &quot;moderate&quot; (sensible with slight pain), or &quot;severe&quot; (sensible with pain that persists for a while) after a conventional air blast is applied to the study tooth. Changes in the frequency of categories will be determined and compared between the two treatment arms. An improvement is defined as a decreased reaction (for example, severe to mild), a deterioration is defined as increased reaction (for example, none to moderate), and unchanged is no change to reaction (for example, mild to mild).</description>
          <population>ITT data set study teeth. Baseline collected at either visit 1 or visit 2 based on different versions of CIP.</population>
          <units>Study Teeth</units>
          <param>Count of Units</param>
          <units_analyzed>Study Teeth</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="51"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Study Teeth</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="159"/>
                <count group_id="O2" value="156"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Improvement in Root Dentin Hypersensitivity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44"/>
                    <measurement group_id="O2" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Deterioration in Root Dentin Hypersensitivity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unchanged Root Dentin Hypersensitivity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="107"/>
                    <measurement group_id="O2" value="106"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Post-surgical Pain</title>
        <description>Post-surgical pain will be measured on a 100 millimeter visual analog scale. The range is 0 (no pain) to 99 (nearly maximum pain). The lower the value, the better the outcome. The subjects will be instructed to mark their level of pain on a line for both the test quadrant and the control quadrant. The average change in pain level will be determined and compared between the two arms.</description>
        <time_frame>1-2 days post surgery, 1 week post surgery, and 2 weeks post surgery</time_frame>
        <population>ITT dataset.</population>
        <group_list>
          <group group_id="O1">
            <title>Test (With Emdogain)</title>
            <description>Scaling and root planing with Emdogain
Scaling and root planing: Using minimally invasive surgical procedure (scaling and root planing) with Emdogain application to treat one contra-lateral quadrant in subject's jaw.
Emdogain application: Using minimally invasive surgical procedure (scaling and root planing) with Emdogain application to treat one contra-lateral quadrant in subject's jaw</description>
          </group>
          <group group_id="O2">
            <title>Control (Without Emdogain)</title>
            <description>Scaling and root planing without Emdogain
Scaling and root planing without Emdogain: Using minimally invasive surgical procedure (scaling and root planing) without Emdogain application to treat one contra-lateral quadrant in subject's jaw.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Post-surgical Pain</title>
          <description>Post-surgical pain will be measured on a 100 millimeter visual analog scale. The range is 0 (no pain) to 99 (nearly maximum pain). The lower the value, the better the outcome. The subjects will be instructed to mark their level of pain on a line for both the test quadrant and the control quadrant. The average change in pain level will be determined and compared between the two arms.</description>
          <population>ITT dataset.</population>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pain Level 1-2 days post sx.</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.3" spread="22.6"/>
                    <measurement group_id="O2" value="12.9" spread="20.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain level 1 week post sx</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.8" spread="20.6"/>
                    <measurement group_id="O2" value="8.1" spread="19.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain Level 2 weeks post sx.</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.0" spread="16.6"/>
                    <measurement group_id="O2" value="5.0" spread="13.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to 12 months.</time_frame>
      <desc>All participants received both interventions and adverse events were not collected with regard to separate intervention.</desc>
      <group_list>
        <group group_id="E1">
          <title>All Participants</title>
          <description>All Participants</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Breast Cancer diagnosis</sub_title>
                <description>Subject diagnosed with breast cancer. Unrelated to device or procedure</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Extensive tooth decay</sub_title>
                <description>Extensive tooth decay site #31. Unrelated to device or procedure.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Mild discomfort when chewing</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>mild discomfort with chewing. Possibly related to procedure.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Retrained bony sequestrum</sub_title>
                <description>Retained bony sequestrum. Unrelated to device or procedure.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Generalized sensation of burning mouth</sub_title>
                <description>Generalized sensation of burning mouth. Unrelated to device or procedure.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Itching skin reaction gum</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Itching skin reaction gum. Possibly related to device or procedure.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Fracture of Veneer #21</sub_title>
                <description>Fracture of veneer #21. Unrelated to device or procedure.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Hematoma</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Hematoma right side above tooth # 5 and #6. Approx 2-3 cms big. No pain. Definitely related to procedure.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Tooth fracture #23</sub_title>
                <description>Tooth Fracture #23. Unrelated to device or procedure.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Apical periodontitis</sub_title>
                <description>Apical periodontitis. Unrelated to device or procedure.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Abscess on extracted tooth #20</sub_title>
                <description>Abscess on tooth #20. Not study tooth. Unrelated to device or procedure.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Bleeding and mobility at #24 and 28</sub_title>
                <description>Bleeding and mobility at teeth #24 and #28. Unrelated to device or procedure.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Loosening of bridge</sub_title>
                <description>Loosening of bridge. Unrelated to device or procedure.</description>
                <counts group_id="E1" events="4" subjects_affected="1" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Sensitivity to cold teeth # 4,5,7 and 9-11</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Sensitivity to cold teeth # 4,5,7 and 9-11. Possibly related to procedure.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Unclear tooth complaint #5 and #6</sub_title>
                <description>Unclear tooth complaint #5 and #6. Unrelated to device or procedure.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Restoration prosthetic problem</sub_title>
                <description>Restoration prosthetic problem. Unrelated to device or procedure.</description>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Hypersensitivity to pain # 22 and 25-28</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Hypersensitivity to pain #22 and 25-28. Possibly related to procedure.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Sensitivity to warmth and cold # 19,21,22,25,27-29</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Sensitivity to warmth and cold #19,21,22,25,27-29. Definitely related to procedure.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Sinus Infection</sub_title>
                <description>Subject reported sinus infection. Unrelated to device or procedure.</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cold/Flu</sub_title>
                <description>Cold/Flu. Unrelated to device or procedure.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Itching skin reaction neck area, external</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Itching skin reaction neck area, external, no pain. Possibly related to device.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Manfred Klasser</name_or_title>
      <organization>GWD Consult</organization>
      <phone>+49 6108 825 65 20</phone>
      <email>manfred.klasser@gwd-consult.de</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

